Recent Finacing
Recent Raise
Astrocyte Pharmaceuticals is a clinical-stage biopharmaceutical company developing AST-004, a small-molecule astrocyte-targeting neuroprotective therapy in Phase 1B for stroke, traumatic brain injury, and Alzheimer's preclinical models.
